These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29247125)

  • 21. The effect of rheumatoid arthritis on patient-reported outcomes following knee and hip replacement: evidence from routinely collected data.
    Burn E; Edwards CJ; Murray DW; Silman A; Cooper C; Arden NK; Pinedo-Villanueva R; Prieto-Alhambra D
    Rheumatology (Oxford); 2019 Jun; 58(6):1016-1024. PubMed ID: 30608608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis.
    Zhou VY; Lacaille D; Lu N; Kopec JA; Qian Y; Nosyk B; Aviña-Zubieta JA; Esdaile JM; Xie H
    Rheumatology (Oxford); 2023 Dec; 62(12):3858-3865. PubMed ID: 37014364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.
    Jørgensen TS; Kristensen LE; Christensen R; Bliddal H; Lorenzen T; Hansen MS; Østergaard M; Jensen J; Zanjani L; Laursen T; Butt S; Dam MY; Lindegaard HM; Espesen J; Hendricks O; Kumar P; Kincses A; Larsen LH; Andersen M; Næser EK; Jensen DV; Grydehøj J; Unger B; Dufour N; Sørensen V; Vildhøj S; Hansen IM; Raun J; Krogh NS; Hetland ML
    Rheumatology (Oxford); 2015 Dec; 54(12):2156-65. PubMed ID: 26175471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A reliable time-series method for predicting arthritic disease outcomes: New step from regression toward a nonlinear artificial intelligence method.
    Bonakdari H; Pelletier JP; Martel-Pelletier J
    Comput Methods Programs Biomed; 2020 Jun; 189():105315. PubMed ID: 31972347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed anti-TNF therapy increases the risk of total knee replacement in patients with severe rheumatoid arthritis.
    Chen YC; Chiu WC; Cheng TT; Lai HM; Yu SF; Su BY; Hsu CY; Ko CH; Chen JF
    BMC Musculoskelet Disord; 2017 Aug; 18(1):326. PubMed ID: 28764690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy: A prospective observational study of patients registered in the south Swedish SSATG registry.
    Jørgensen TS; Turesson C; Kapetanovic M; Englund M; Turkiewicz A; Christensen R; Bliddal H; Geborek P; Kristensen LE
    PLoS One; 2017; 12(2):e0169946. PubMed ID: 28151971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors associated with initiation of a biologic disease modifying anti-rheumatic drug in patients with rheumatoid arthritis: A nested case-control study on 34,925 patients.
    Park EH; Shin A; Ha YJ; Lee YJ; Lee EB; Song YW; Kang EH
    Joint Bone Spine; 2021 Jan; 88(1):105057. PubMed ID: 32711117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fewer and older patients with rheumatoid arthritis need total knee replacement.
    Skyttä ET; Honkanen PB; Eskelinen A; Huhtala H; Remes V
    Scand J Rheumatol; 2012 Oct; 41(5):345-9. PubMed ID: 22827495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts.
    Nikiphorou E; Carpenter L; Morris S; Macgregor AJ; Dixey J; Kiely P; James DW; Walsh DA; Norton S; Young A
    Arthritis Rheumatol; 2014 May; 66(5):1081-9. PubMed ID: 24782174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics.
    Frisell T; Baecklund E; Bengtsson K; Di Giuseppe D; Forsblad-d'Elia H; Askling J;
    Ann Rheum Dis; 2018 May; 77(5):650-657. PubMed ID: 29237621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe infections in Portuguese patients with rheumatoid arthritis under biologic treatment - a multicenter, nationwide study (SIPPRA-B Study).
    Oliveira Pinheiro F; Seabra Rato M; Madureira P; Araújo F; Salvador MJ; Fraga V; Brites L; Cunha Santos F; Silva A; Lopes AR; Cruz M; Vilas Boas JP; Pontes Ferreira M; Samões B; Beirão T; Santos I; Carvalho D; Costa L; Bernardes M
    ARP Rheumatol; 2023; 2(2):111-119. PubMed ID: 37421190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do biologic drugs affect the need for and outcome of joint replacements in patients with rheumatoid arthritis? A register-based study.
    Aaltonen KJ; Virkki LM; Jämsen E; Sokka T; Konttinen YT; Peltomaa R; Tuompo R; Yli-Kerttula T; Kortelainen S; Ahokas-Tuohinto P; Blom M; Nordström DC
    Semin Arthritis Rheum; 2013 Aug; 43(1):55-62. PubMed ID: 23481417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden.
    Wadström H; Frisell T; Askling J;
    JAMA Intern Med; 2017 Nov; 177(11):1605-1612. PubMed ID: 28975211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study.
    Joensuu JT; Aaltonen KJ; Aronen P; Sokka T; Puolakka K; Tuompo R; Korpela M; Vasala M; Ilva K; Nordström D; Blom M
    Rheumatology (Oxford); 2016 Oct; 55(10):1803-11. PubMed ID: 27354689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of gastrointestinal bleeding in patients undergoing total hip or knee replacement compared with matched controls: a nationwide cohort study.
    Lalmohamed A; Vestergaard P; Javaid MK; de Boer A; Leufkens HG; van Staa TP; de Vries F
    Am J Gastroenterol; 2013 Aug; 108(8):1277-85. PubMed ID: 23629603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential benefits of biologics on stroke and mortality in patients with rheumatoid arthritis: A nationwide population-based cohort study in Taiwan.
    Tang CH; Yu F; Huang CY; Chen DY
    Int J Rheum Dis; 2019 Aug; 22(8):1544-1552. PubMed ID: 31240863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBIT.
    Gerhold K; Richter A; Schneider M; Bergerhausen HJ; Demary W; Liebhaber A; Listing J; Zink A; Strangfeld A
    Rheumatology (Oxford); 2015 Oct; 54(10):1858-66. PubMed ID: 26001633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on the prevalence and incidence of rheumatoid arthritis in Korea and an analysis of medical care and drug utilization.
    Won S; Cho SK; Kim D; Han M; Lee J; Jang EJ; Sung YK; Bae SC
    Rheumatol Int; 2018 Apr; 38(4):649-656. PubMed ID: 29302803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.
    Gabay C; Riek M; Scherer A; Finckh A;
    Rheumatology (Oxford); 2015 Sep; 54(9):1664-72. PubMed ID: 25922549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Timing of acute myocardial infarction in patients undergoing total hip or knee replacement: a nationwide cohort study.
    Lalmohamed A; Vestergaard P; Klop C; Grove EL; de Boer A; Leufkens HG; van Staa TP; de Vries F
    Arch Intern Med; 2012 Sep; 172(16):1229-35. PubMed ID: 22826107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.